Cellaria, LLC , a scientific innovator that develops revolutionary new patient-specific cancer models for challenging tumors, today announced the formation of a strategic partnership with AMS Biotechnology . As part of the agreement, AMSBIO will distribute, market and sell Cellaria cell models and culture media throughout Europe.